Compare Humana Inc (HUM) vs MPLX LP (MPLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs MPLX LP — how do they compare? Humana Inc trades at $439.56 (market cap $47.61B), while MPLX LP trades at $57.42 (market cap $57.84B). The key difference: MPLX LP is the larger of the two by market cap, and MPLX LP pays the higher dividend (7.55%). Which is the better fit depends on your goals.
| HUM | MPLX | |
|---|---|---|
Market Cap | $47.61B | $57.84B |
Volume | 1,827,332 | 1,104,749 |
Sector | Health | Energy |
52-Week High | $409.85 | $60.51 |
52-Week Low | $163.67 | $47.80 |
Typical Hold Time | 53 Days | — |
Enterprise Value | $54.97B | $82.94B |
Dividend Yield | 0.89% | 7.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
MPLX trades at $57.05, down 1.25% with a bearish technical signal. The company maintains strong profitability with 40.45% net income margin and 33.95% ROE, though recent earnings missed expectations in two consecutive quarters. Analyst consensus remains strongly bullish with a $63.80 price target, representing 12% upside potential. Recent news highlights MPLX's resilience in volatile energy markets through fee-based revenue models and strong distribution coverage.
The outlook remains positive given strong cash flow generation and dividend sustainability, though risks include energy market volatility and recent earnings misses. With 68% analyst buy ratings and solid fundamentals, MPLX presents a compelling income opportunity despite near-term technical weakness and sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About MPLX LP
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →
